{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:58:49Z","timestamp":1781668729907,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bronchiectasis is a progressive pulmonary disease with repeated cough, expectoration and frequent respiratory infections. Every patient should have sample collected for routine bacteriological culture. Determining the disease\u2019s severity can help with therapy and follow-up choices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim of the study<\/jats:title>\n                    <jats:p>To detect the bacteriology of bronchiectasis patients and relation to disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>60 patients with bronchiectasis exacerbation were investigated at chest department of Fayoum University Hospital. Broncho alveolar lavage for culture and sensitivity was done. Disease severity was assessed by cough score, mMRC dyspnea score, oxygen saturation, no of lobes affected in CT chest and modified rieff score, Spirometry and classification of severity by FEV1, and finally FACED and BSI scores were calculated. Isolation of H.Influenza represents 40%, Pseudomonas represents 26.7%, Klebsiella represents 20%, Staph aureus represents 10% and Pseudomonas&amp; Klebsiella represent 3.3%. There was a statistically significant lower mean of oxygen saturation in cases infected with both pseudomonas and Klebsiella. There was a statistically significant high percentage of mild Modified Reiff score among cases infected with H. influenza, moderate degree among cases infected with Klebsiella, but severe degree among cases infected with pseudomonas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>H. influenzae consider as a major pathogen isolated by BAL culture in patients with bronchiectasis exacerbation, followed by P. aeruginosa, then klebsiella then S. aureus. Cases infected with P. aeruginosa and klebsiella have the worst oxygen saturation. The highest modified Rieff score was in P. aeruginosa than other isolated organisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04378-w","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:26:09Z","timestamp":1781666769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The bacteriology of bronchiectasis patients and relation to disease severity"],"prefix":"10.1186","volume":"26","author":[{"given":"Enas Sayed","family":"Farhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan Mahmoud","family":"Abd el Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assem Fouad","family":"Elessawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa Ahmed","family":"Elhefny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Ibrahim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany Mahmoud","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar Ahmed","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"20","key":"4378_CR1","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.4103\/0366-6999.167360","volume":"128","author":"XY Miao","year":"2015","unstructured":"Miao XY, Ji XB, Lu HW, et al. Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review. Chin Med J (Engl). 2015;128(20):2792\u20137.","journal-title":"Chin Med J (Engl)"},{"key":"4378_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2012.09.011","volume":"55","author":"JD Chalmers","year":"2013","unstructured":"Chalmers JD, Hill AT. Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis. Mol Immunol. 2013;55:27\u201334.","journal-title":"Mol Immunol"},{"key":"4378_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.arbres.2017.07.015","volume":"54","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2018","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, M\u00e1iz L, et al. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults. Arch Bronconeumol. 2018;54:79\u201387.","journal-title":"Arch Bronconeumol"},{"key":"4378_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","volume":"186","author":"JD Chalmers","year":"2012","unstructured":"Chalmers JD, Smith MP, et al. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012;186:657\u201365.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4378_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212468","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019;74(1):1\u201369.","journal-title":"Thorax"},{"key":"4378_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","volume":"12","author":"MA Martinez-Garcia","year":"2017","unstructured":"Martinez-Garcia MA, Athanazio RA, et al. Predicting high risk of exacerbations in bronchiectasis: The E-FACED score. Int J COPD. 2017;12:275\u201384.","journal-title":"Int J COPD"},{"issue":"1","key":"4378_CR7","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thx.2010.136119","volume":"65","author":"MC Pasteur","year":"2010","unstructured":"Pasteur MC, Bilton D, et al. British Thoracic Society guidelines for non-CF bronchiectasis. Thorax. 2010;65(1):i1\u201358.","journal-title":"Thorax"},{"key":"4378_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/2225-6482.198488","volume":"3","author":"P Faverio","year":"2016","unstructured":"Faverio P, Zucchetti SC, et al. Phenotyping in bronchiectasis: Are we moving toward a personalized medicine? Community Acquir Infect. 2016;3:96\u2013103.","journal-title":"Community Acquir Infect"},{"key":"4378_CR9","first-page":"44","volume":"52","author":"DB Reiff","year":"2011","unstructured":"Reiff DB, Wells AU, et al. CT findings in bronchiectasis: limited value in distinguishing between. Eur Respir Mon. 2011;52:44\u201367.","journal-title":"Eur Respir Mon"},{"key":"4378_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1183\/13993003.01717-2015","volume":"47","author":"WJ Guan","year":"2016","unstructured":"Guan WJ, Chen RC, et al. The bronchiectasis severity index and FACED score for bronchiectasis. Eur Respir J. 2016;47:382\u20134.","journal-title":"Eur Respir J"},{"issue":"1","key":"4378_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4187\/respcare.05636","volume":"63","author":"AB Munari","year":"2018","unstructured":"Munari AB, Gulart AA, et al. Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living. Respir Care. 2018;63(1):77\u201385.","journal-title":"Respir Care"},{"key":"4378_CR12","doi-asserted-by":"publisher","first-page":"2002990","DOI":"10.1183\/13993003.02990-2020","volume":"58","author":"AB Chang","year":"2021","unstructured":"Chang AB, Fortescue R, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J. 2021;58:2002990.","journal-title":"Eur Respir J"},{"key":"4378_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccm.2021.12.004","volume":"43","author":"AE O\u2019Donnell","year":"2022","unstructured":"O\u2019Donnell AE. Airway Clearance and Mucoactive Therapies in Bronchiectasis. Clin Chest Med. 2022;43:157\u201363.","journal-title":"Clin Chest Med"},{"key":"4378_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","volume":"43","author":"MA Mart\u00ednez-Garc\u00eda","year":"2014","unstructured":"Mart\u00ednez-Garc\u00eda MA, de Gracia J, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: The FACED score. Eur Respir J. 2014;43:1357\u201367.","journal-title":"Eur Respir J"},{"key":"4378_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","volume":"4","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chang AB, et al. Bronchiactasis Nat Reviews Disease Primers. 2018;4:45.","journal-title":"Bronchiactasis Nat Reviews Disease Primers"},{"key":"4378_CR16","doi-asserted-by":"publisher","first-page":"2200611","DOI":"10.1183\/13993003.00611-2022","volume":"61","author":"R Dhar","year":"2023","unstructured":"Dhar R, Singh S, et al. Clinical outcomes of bronchiectasis in India: data from the EMBARC\/Respiratory Research Network of India registry. Eur Respir J. 2023;61:2200611.","journal-title":"Eur Respir J"},{"key":"4378_CR17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","volume":"187","author":"MM Tunney","year":"2013","unstructured":"Tunney MM, Einarsson GG, et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med. 2013;187:1118\u201326.","journal-title":"Am J Respir Crit Care Med"},{"key":"4378_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","volume":"183","author":"MP Murray","year":"2011","unstructured":"Murray MP, Govan JR, et al. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2011;183:491\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4378_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","volume":"11","author":"GB Rogers","year":"2014","unstructured":"Rogers GB, Zain NM, et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Annals Am Thorac Soc. 2014;11(4):496\u2013503.","journal-title":"Annals Am Thorac Soc"},{"key":"4378_CR20","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1513\/AnnalsATS.201506-333OC","volume":"12","author":"S Finch","year":"2015","unstructured":"Finch S, McDonnell MJ, et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12:1602\u201311.","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"4378_CR21","doi-asserted-by":"publisher","first-page":"e0183553","DOI":"10.1371\/journal.pone.0183553","volume":"12","author":"MK Byun","year":"2017","unstructured":"Byun MK, Chang J, et al. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis. PLoS ONE. 2017;12(8):e0183553.","journal-title":"PLoS ONE"},{"issue":"11","key":"4378_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/jcm7110429","volume":"7","author":"SH Lee","year":"2018","unstructured":"Lee SH, Lee Y, et al. Characterization of microbiota in bronchiectasis patients with different disease severities. J Clin Med. 2018;7(11):429.","journal-title":"J Clin Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04378-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04378-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04378-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:38:03Z","timestamp":1781667483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04378-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04378-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethics approval was obtained from the Faculty of Medicine Research Ethical Committee (approval number M583), Fayoum university and the participants were informed about the study\u2019s purpose, the examination, and the investigation that would be done, in addition to the confidentiality of their information and their freedom to refuse participation. Informed consent was supplied by all individuals before being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}